daclizumab - injection, Zenapax
GENERIC NAME: DACLIZUMAB - INJECTION (dack-LIZ-you-mab)
BRAND NAME(S): Zenapax
USES: Daclizumab is used to prevent rejection of a kidney transplant. It works by weakening your body's defense system (immune system) to help your body accept the new kidney as if it were your own. This medication is a monoclonal antibody and belongs to a class of drugs known as immunosuppressants. It is used in combination with other immunosuppressant drugs (e.g., cyclosporine, corticosteroids such as prednisone).
HOW TO USE: This medication is given by injection into a vein by a health care professional. This medication is given over 15 minutes, usually every 14 days for a total of 5 doses, with the first dose given within 24 hours before transplantation, or as directed by your doctor. If you have any questions about the use of this medication, consult your doctor or pharmacist.Dosage is based on your medical condition, weight, and response to treatment.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index